Search Results

Filter
  • 1-10 of  136,354 results for ""MYELODYSPLASTIC syndromes""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/classification ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics

  • Source: The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e862-e872. Date of Electronic Publication: 2024 Oct 09.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype.

  • Authors : Huang N; Department of Hematology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Chang C

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis ; Mutation*

  • Source: Annals of hematology [Ann Hematol] 2024 Nov; Vol. 103 (11), pp. 4485-4495. Date of Electronic Publication: 2024 Sep 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Increased ferroptosis of erythrocytes is associated with myelodysplastic syndromes.

  • Authors : Zhang M; Department of Hematology, General Hospital, Tianjin Medical University, 154 Anshandao, Heping District, Tianjin, 300052, China.; Liu M

Subjects: Ferroptosis* ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/pathology ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/metabolism

  • Source: Annals of hematology [Ann Hematol] 2024 Oct; Vol. 103 (10), pp. 4009-4020. Date of Electronic Publication: 2024 Aug 23.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.

  • Authors : Wery AR; Department of Hematology, Institut Jules Bordet, Rue Meylemeersch, 90. 1070, Brussels, Belgium. .; Salaroli A

Subjects: Neoplasm, Residual* ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/mortality

  • Source: Annals of hematology [Ann Hematol] 2024 Nov; Vol. 103 (11), pp. 4671-4685. Date of Electronic Publication: 2024 Oct 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-synthetase and myelodysplastic syndromes with deep morphea: an example of shared immunopathogenesis? A case-based review.

  • Authors : Hernández-López A; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Reyna-Juárez Y

Subjects: Myositis*/Myositis*/Myositis*/immunology ; Myositis*/Myositis*/Myositis*/drug therapy ; Myositis*/Myositis*/Myositis*/diagnosis Antisynthetase syndrome

  • Source: Rheumatology international [Rheumatol Int] 2024 Nov; Vol. 44 (11), pp. 2645-2652. Date of Electronic Publication: 2024 Sep 09.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Incorporation mutational profile might reduce the importance of blast count in prognostication of low-risk myelodysplastic syndromes.

  • Authors : García-Culebras M; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Sevilla, Spain.; Alcalde P

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/mortality ; Mutation*

  • Source: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1765-1772. Date of Electronic Publication: 2024 Aug 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation.

  • Authors : Wang H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/mortality

  • Source: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1899-1909. Date of Electronic Publication: 2024 Aug 13.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Myelodysplastic syndromes among atomic bomb survivors in Nagasaki: similarities to and differences from de novo and therapy-related cases.

  • Authors : Ando K; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan.; Miyazaki Y

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/etiology ; Atomic Bomb Survivors*

  • Source: Journal of radiation research [J Radiat Res] 2024 Dec 15; Vol. 65 (Supplement_1), pp. i88-i96.Publisher: Oxford University Press Country of Publication: England NLM ID: 0376611 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Patient-reported outcomes in early phase trials for patients with myelodysplastic syndromes.

  • Authors : Mendoza T; Office of Patient-Centered Outcomes Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: .; King AL

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/drug therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/therapy

  • Source: Seminars in hematology [Semin Hematol] 2024 Dec; Vol. 61 (6), pp. 457-464. Date of Electronic Publication: 2024 Oct 30.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0404514 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

RNA splicing as a therapeutic target in myelodysplastic syndromes.

  • Authors : Tseng CC; Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.; Obeng EA

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/drug therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/metabolism

  • Source: Seminars in hematology [Semin Hematol] 2024 Dec; Vol. 61 (6), pp. 431-441. Date of Electronic Publication: 2024 Oct 23.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0404514 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  136,354 results for ""MYELODYSPLASTIC syndromes""